Fact CheckerSign in

NCT06189807Active, not recruiting

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD)

Pregnancy and Contraception Education in Chronic Kidney Disease (PACE-CKD): A Pilot Study

Source: ClinicalTrials.gov · Last updated 12 Nov 2025

Brief summary (registry, in English)

This pilot study will assess the efficacy of a pregnancy and contraception education decision aid (DA) for patients with chronic kidney disease to support decisions about reproductive health, and will assess feasibility and acceptability of the intervention to inform future Research Project Grant (R01) level studies.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
18 Dec 2023
Start date
14 Feb 2024
Primary completion date
24 Sept 2025
Lead sponsor
University of Michigan
NCT number
NCT06189807

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 14 Feb 2024 to the primary completion date, 24 Sept 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients receiving dialysis
  • Patients who have a kidney transplant

Other illness

  • Patients that have significant cognitive or visual impairment that limits interaction with the decision aid (DA)

Other

  • Patients that are surgically sterile (tubal ligation or hysterectomy) or currently pregnant

Who the study is looking for

  • Any Chronic Kidney Disease (CKD) diagnosis
  • CKD defined as abnormality in kidney structure or function for \>3 months and may be manifested by having any one of the following:
    • Glomerular filtration rate (GFR)\<60 milliliter/Minute (ml/min)/1.73m2, or
  • A marker of kidney damage (albuminuria \>30 milligrams per gram (mg/g), abnormal kidney histology by biopsy, hematuria, structural abnormalities by imaging (e.g. polycystic kidney disease, horseshoe kidney) or electrolyte abnormalities due to tubular disorders)
    • \- Able to speak and read English

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Michigan
Coordinator of this site? Confirm its status
Ann ArborUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.